Literature DB >> 25644981

The diffeomorphometry of regional shape change rates and its relevance to cognitive deterioration in mild cognitive impairment and Alzheimer's disease.

Xiaoying Tang1, Dominic Holland, Anders M Dale, Laurent Younes, Michael I Miller.   

Abstract

We proposed a diffeomorphometry-based statistical pipeline to study the regional shape change rates of the bilateral hippocampus, amygdala, and ventricle in mild cognitive impairment (MCI) and Alzheimer's disease (AD) compared with healthy controls (HC), using sequential magnetic resonance imaging (MRI) scans of 713 subjects (3,123 scans in total). The subgroup shape atrophy rates of the bilateral hippocampus and amygdala, as well as the expansion rates of the bilateral ventricles, for a majority of vertices were found to follow the order of AD>MCI>HC. The bilateral hippocampus and the left amygdala were subsegmented into multiple functionally meaningful subregions with the help of high-field MRI scans. The largest group differences in localized shape atrophy rates on the hippocampus were found to occur in CA1, followed by subiculum, CA2, and finally CA3/dentate gyrus, which is consistent with the neurofibrillary tangle accumulation trajectory. Highly nonuniform group differences were detected on the amygdala; vertices on the core amygdala (basolateral and lateral nucleus) revealed much larger atrophy rates, whereas those on the noncore amygdala (mainly centromedial) displayed similar or even smaller atrophy rates in AD relative to HC. The temporal horns of the ventricles were observed to have the largest localized ventricular expansion rate differences; with the AD group showing larger localized expansion rates on the anterior horn and the body part of the ventricles as well. Significant correlations were observed between the localized shape change rates of each of these six structures and the cognitive deterioration rates as quantified by the Alzheimer's Disease Assessment Scale-Cognitive Behavior Section increase rate and the Mini Mental State Examination decrease rate.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  Alzheimer's disease; diffeomorphometry; longitudinal analysis; medial temporal lobe; mild cognitive impairment; regional shape change rates

Mesh:

Year:  2015        PMID: 25644981      PMCID: PMC4474005          DOI: 10.1002/hbm.22758

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  100 in total

1.  Cognitive and neural mechanisms of emotional memory.

Authors:  S Hamann
Journal:  Trends Cogn Sci       Date:  2001-09-01       Impact factor: 20.229

2.  Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain.

Authors:  Bruce Fischl; David H Salat; Evelina Busa; Marilyn Albert; Megan Dieterich; Christian Haselgrove; Andre van der Kouwe; Ron Killiany; David Kennedy; Shuna Klaveness; Albert Montillo; Nikos Makris; Bruce Rosen; Anders M Dale
Journal:  Neuron       Date:  2002-01-31       Impact factor: 17.173

3.  Normalized accurate measurement of longitudinal brain change.

Authors:  S M Smith; N De Stefano; M Jenkinson; P M Matthews
Journal:  J Comput Assist Tomogr       Date:  2001 May-Jun       Impact factor: 1.826

Review 4.  A meta-analysis of hippocampal atrophy rates in Alzheimer's disease.

Authors:  Josephine Barnes; Jonathan W Bartlett; Laura A van de Pol; Clement T Loy; Rachael I Scahill; Chris Frost; Paul Thompson; Nick C Fox
Journal:  Neurobiol Aging       Date:  2008-03-17       Impact factor: 4.673

5.  Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls.

Authors:  Jonathan H Morra; Zhuowen Tu; Liana G Apostolova; Amity E Green; Christina Avedissian; Sarah K Madsen; Neelroop Parikshak; Arthur W Toga; Clifford R Jack; Norbert Schuff; Michael W Weiner; Paul M Thompson
Journal:  Neuroimage       Date:  2008-11-08       Impact factor: 6.556

6.  The detection and significance of subtle changes in mixed-signal brain lesions by serial MRI scan matching and spatial normalization.

Authors:  L Lemieux; U C Wieshmann; N F Moran; D R Fish; S D Shorvon
Journal:  Med Image Anal       Date:  1998-09       Impact factor: 8.545

7.  Amygdala atrophy is prominent in early Alzheimer's disease and relates to symptom severity.

Authors:  Stéphane P Poulin; Rebecca Dautoff; John C Morris; Lisa Feldman Barrett; Bradford C Dickerson
Journal:  Psychiatry Res       Date:  2011-09-14       Impact factor: 3.222

8.  4D deformation modeling of cortical disease progression in Alzheimer's dementia.

Authors:  A L Janke; G de Zubicaray; S E Rose; M Griffin; J B Chalk; G J Galloway
Journal:  Magn Reson Med       Date:  2001-10       Impact factor: 4.668

9.  Volumetry of amygdala and hippocampus and memory performance in Alzheimer's disease.

Authors:  Michael Basso; John Yang; Lauren Warren; Martha G MacAvoy; Pradeep Varma; Richard A Bronen; Christopher H van Dyck
Journal:  Psychiatry Res       Date:  2006-03-09       Impact factor: 3.222

10.  Rates of decline in Alzheimer disease decrease with age.

Authors:  Dominic Holland; Rahul S Desikan; Anders M Dale; Linda K McEvoy
Journal:  PLoS One       Date:  2012-08-02       Impact factor: 3.240

View more
  22 in total

1.  Surface-based vertexwise analysis of morphometry and microstructural integrity for white matter tracts in diffusion tensor imaging: With application to the corpus callosum in Alzheimer's disease.

Authors:  Xiaoying Tang; Yuanyuan Qin; Wenzhen Zhu; Michael I Miller
Journal:  Hum Brain Mapp       Date:  2017-01-13       Impact factor: 5.038

Review 2.  Baby brain atlases.

Authors:  Kenichi Oishi; Linda Chang; Hao Huang
Journal:  Neuroimage       Date:  2018-04-03       Impact factor: 6.556

3.  Anomalous subcortical morphology in boys, but not girls, with ADHD compared to typically developing controls and correlates with emotion dysregulation.

Authors:  Karen E Seymour; Xiaoying Tang; Deana Crocetti; Stewart H Mostofsky; Michael I Miller; Keri S Rosch
Journal:  Psychiatry Res Neuroimaging       Date:  2017-01-06       Impact factor: 2.376

4.  Predicting auditory feedback control of speech production from subregional shape of subcortical structures.

Authors:  Xiaoying Tang; Na Chen; Siyun Zhang; Jeffery A Jones; Baofeng Zhang; Jingyuan Li; Peng Liu; Hanjun Liu
Journal:  Hum Brain Mapp       Date:  2017-10-23       Impact factor: 5.038

5.  Nonparametric Aggregation of Geodesic Trends for Longitudinal Data Analysis.

Authors:  Kristen M Campbell; P Thomas Fletcher
Journal:  Shape Med Imaging (2018)       Date:  2018-11-23

6.  Education is associated with sub-regions of the hippocampus and the amygdala vulnerable to neuropathologies of Alzheimer's disease.

Authors:  Xiaoying Tang; Vijay R Varma; Michael I Miller; Michelle C Carlson
Journal:  Brain Struct Funct       Date:  2016-08-17       Impact factor: 3.270

7.  Differential 5-year brain atrophy rates in cognitively declining and stable APOE-ε4 elders.

Authors:  Dana A Kelly; Michael Seidenberg; Katherine Reiter; Kristy A Nielson; John L Woodard; J Carson Smith; Sally Durgerian; Stephen M Rao
Journal:  Neuropsychology       Date:  2018-06-18       Impact factor: 3.295

8.  Associations of amygdala volume and shape with transactive response DNA-binding protein 43 (TDP-43) pathology in a community cohort of older adults.

Authors:  Nazanin Makkinejad; Julie A Schneider; Junxiao Yu; Sue E Leurgans; Aikaterini Kotrotsou; Arnold M Evia; David A Bennett; Konstantinos Arfanakis
Journal:  Neurobiol Aging       Date:  2019-01-31       Impact factor: 4.673

9.  BIOMARKER CHANGE-POINT ESTIMATION WITH RIGHT CENSORING IN LONGITUDINAL STUDIES.

Authors:  Xiaoying Tang; Michael I Miller; Laurent Younes
Journal:  Ann Appl Stat       Date:  2017-09       Impact factor: 2.083

10.  APOE Affects the Volume and Shape of the Amygdala and the Hippocampus in Mild Cognitive Impairment and Alzheimer's Disease: Age Matters.

Authors:  Xiaoying Tang; Dominic Holland; Anders M Dale; Michael I Miller
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.